Open main menu

Psychiatrienet β

Difference between revisions of "Project:Background"

(Editor-in-chief)
 
(21 intermediate revisions by 5 users not shown)
Line 4: Line 4:
 
===Mission statement===
 
===Mission statement===
 
To improve independently psychopharmacotherapy and medication safety for all patients.
 
To improve independently psychopharmacotherapy and medication safety for all patients.
 
===Editor-in-chief===
 
'''Asmar Al Hadithy (PhD PharmD) is the current editor-in-chief of this WIKI'''.
 
[[image:Logo_apotheek_klein.jpg|left|135px|Parnassia Group Pharmacy]]
 
He is now chief hospital pharmacist and head of the clinical pharmacy department of Parnassia Psychiatry Institute. <br clear="all">
 
  
 
===Acknowledgements===
 
===Acknowledgements===
 +
* ''' Walter Broekema,MSc, PharmD''': founder and past-editor-in-chief (2008-2018)
 
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines
 
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines
* '''Walter Broekema is the founder and past-editor-in-chief'''
 
 
* ''' Sietske Brouwer, MSc, PharmD''': maintenance
 
* ''' Sietske Brouwer, MSc, PharmD''': maintenance
 
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions
 
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions
Line 26: Line 21:
 
* ''' Mathilde van Veggel, MSc, PharmD''': maintenance
 
* ''' Mathilde van Veggel, MSc, PharmD''': maintenance
 
* ''' Anoek Verbeij, Bsc ''': maintenance
 
* ''' Anoek Verbeij, Bsc ''': maintenance
 +
* ''' Joost van Raaij, MSc, PharmD''': maintenance
 +
* ''' Casper van der Hoeven, MSc, PharmD''': maintenance
 +
* ''' Ken Ho Hua, MSc, PharmD''': maintenance
  
 
=== Work in progress ===
 
=== Work in progress ===
We are gradually improving the tables by adding more references, graphics etc. This will take time.
+
We are gradually improving the tables by adding more references, graphics etc. An overview of the most recent changes can be found on this page:
  
 +
[[Updates Switch Tables]]
 
   
 
   
  

Latest revision as of 12:09, 18 March 2022

More information and/or sources of switching antidepressants and antipsychotics

Mission statement

To improve independently psychopharmacotherapy and medication safety for all patients.

Acknowledgements

  • Walter Broekema,MSc, PharmD: founder and past-editor-in-chief (2008-2018)
  • Ralph de Backer, MSc, PharmD: benzodiazepines
  • Sietske Brouwer, MSc, PharmD: maintenance
  • Jaap Kerkvliet, MSc, PharmD: flagged revisions
  • Klaas Kooistra, MSc, PharmD: moodstabilizers
  • Hélène Lichtenberg, MSc, PharmD: hypericum switches
  • Ashni Lo-Kim-Lin, MSc, PharmD: general
  • Lenneke Minjon, MSc, PharmD: plain stopping antidepressants
  • Alexandra Mulder, MSc, PharmD: antidepressants
  • Verena Mulder, MSc, PharmD: antipsychotics
  • Mariska de Roo, PharmD: general & authorization
  • Arent Storm, MSc: website design & realization, technical and methodological supervision, benzo convertor
  • Arend Veeninga †, psychiatrist, PhD: tester user interface
  • Mathilde van Veggel, MSc, PharmD: maintenance
  • Anoek Verbeij, Bsc : maintenance
  • Joost van Raaij, MSc, PharmD: maintenance
  • Casper van der Hoeven, MSc, PharmD: maintenance
  • Ken Ho Hua, MSc, PharmD: maintenance

Work in progress

We are gradually improving the tables by adding more references, graphics etc. An overview of the most recent changes can be found on this page:

Updates Switch Tables